MarketInOut Stock Screener Log In | Sign Up

Clarity Pharmaceuticals Ltd

Healthcare • Biotechnology • Quote as of 10/28/2026 16:10
Clarity Pharmaceuticals Ltd stock price and volume chart

Company Profile

IndustryBiotechnology
SectorHealthcare
Market Capitalization585.74 mln
Float288 mln
Earnings Date03/04/2027

Piotroski F-Score

3 / 9
Below average

1-Year Forecast

7.20
Transformational upside

Relative Strength

13 / 100
Significantly lagging

ROE

-63.13
Deeply negative

ROA

-57.82
Deeply negative

Business Description

Clarity Pharmaceuticals is an Australian clinical-stage company focused on developing radioactive drug treatments for cancer, operating across both Australia and the United States. Its pipeline includes three key treatments targeting prostate cancer, a broad range of other cancers including breast, lung, and brain tumors, as well as cancers driven by specific hormone receptors. Founded in 2010 and headquartered in Sydney, the company is working to advance these therapies from research through to clinical use.

Key Fundamentals

EPS-0.28
ROE-63.13
RPS0.03
ROIC-795
ROA-57.82
EBITDA, mln-117
EV / EBITDA-5.22
EV / EBIT-5.21
Revenue, mln10.53
EV / Revenue38.69

Quote Details

Last 1.57
Change 0.015 (0.97%)
Open 1.55
Volume 4,140,307
Turnover 6,479,580
Average Volume 2,780,021

Financial Ratios

Leverage Ratio1.07
Current Ratio16.09
Price / Book4.21
Price / Tangible Book4.22

Financial Strength

Piotroski F-Score 3 / 9
1-Year Target Price7.20

Price Performance & Relative Strength

Period Price Performance Relative Strength
1 Week -12.08% 7 / 100   
1 Month -25.83% 10 / 100   
2 Months -33.4% 10 / 100   
6 Months -49.52% 11 / 100   
1 Year -67.53% 7 / 100   



Disclaimer - Privacy Policy - Terms Of Service - Cookie Use Policy - FAQ - Blog